Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06633198Phase 1Active, not recruiting
Phase 1, open-label, single-arm trial. Primary endpoint: Change in cutaneous microvascular function. Started May 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06633198.